Cover Image

Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Mona Darwish, Nancy Lin, Bryan Dirks, David Jaworowicz, Kelly Maxwell, Sanjeev Pathak
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging
by: Akira Sekikawa, et al.
Published: (2025)

Rural–urban disparities of Alzheimer's disease and related dementias: A scoping review
by: Mackenzie Kramer, et al.
Published: (2025)

AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records
by: Sara Knox, et al.
Published: (2025)

Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
by: Steven E. Arnold, et al.
Published: (2024)

Statin use and dementia risk: A systematic review and updated meta‐analysis
by: Fernando Luiz Westphal Filho, et al.
Published: (2025)

Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design
by: Michael K. Leuchter, et al.
Published: (2025)

Chronic cerebral hypoperfusion‐induced myelin loss in normal‐appearing white matter correlates with cognitive decline: insights from moyamoya disease
by: Xinfeng Yu, et al.
Published: (2025)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
by: Bernadette A. Fausto, et al.
Published: (2026)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
by: Alan Cronemberger Andrade, et al.
Published: (2025)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
by: Luke E. Stoeckel, et al.
Published: (2025)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
by: Chao‐Yi Wu, et al.
Published: (2025)

Issue Information
Published: (2026)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
by: Robin C. Hilsabeck, et al.
Published: (2025)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025)

Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
by: Jeffrey Cummings
Published: (2025)

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population
by: John B. Wetmore, et al.
Published: (2024)

Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study
by: Shihao Xu, et al.
Published: (2025)

Assessing social connection for long‐term care home residents: A scoping review of measure content
by: Madalena P. Liougas, et al.
Published: (2024)

The African Initiative for Bioinformatics Online Training in Neurodegenerative Diseases (AI‐BOND): Investing in the next generation of African neuroscientists
by: Bernard Fongang, et al.
Published: (2024)

Site‐level factors affecting nursing home implementation of a personalized music intervention: Qualitative analyses from Music & Memory: A Pragmatic Trial for Nursing Home Residents with Alzheimer's Disease (METRIcAL)
by: Davoodi Natalie, et al.
Published: (2024)

Cardiorespiratory fitness modifies the relationship between arterial stiffness and cerebral blood flow independent of physical activity
by: Brianne M. Breidenbach, et al.
Published: (2025)

The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
by: Burak Yulug, et al.
Published: (2024)

The power of representation: Statistical analysis of diversity in US Alzheimer's disease genetics data
by: Diane Xue, et al.
Published: (2024)

Vestibular‐related dizziness duration and cognitive deficits in older adults
by: Xiaobao Ma, et al.
Published: (2025)

Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea
by: Yeon Hee Kim, et al.
Published: (2024)

Alzheimer's disease drug development pipeline: 2026
by: Jeffrey L. Cummings, et al.
Published: (2026)

First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI
by: Kiran K. Solingapuram Sai, et al.
Published: (2025)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
by: Adam J Paulsen, et al.
Published: (2025)

Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population—An evaluation of the recruitment effort
by: Yue Ma, et al.
Published: (2025)

Anti‐epileptic drug use and subsequent degenerative dementia occurrence
by: Naoki Ikegaya, et al.
Published: (2024)

Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease
by: Victoria L. Fleming, et al.
Published: (2025)

Infusion‐related reactions in donanemab‐treated participants with early symptomatic Alzheimer's disease
by: Paul Ardayfio, et al.
Published: (2026)

Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
by: David Lukacsovich, et al.
Published: (2026)

The plasma p‐tau217/BD‐tau ratio improves biomarker short‐term variability in memory clinic patients
by: Frederikke Kragh Clemmensen, et al.
Published: (2025)

Clinical efficacy of anti‐amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results
by: Stefan Teipel, et al.
Published: (2025)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
by: Mai Othman, et al.
Published: (2026)

Translating NIA‐AA criteria into usual practice: Report from the ReDeMa Project
by: Antonio Sánchez‐Soblechero, et al.
Published: (2024)

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach
by: Jamie C. Fong, et al.
Published: (2026)

A sex‐specific “hormone–bone–brain” axis in Alzheimer's disease: Integrating Global Burden of Disease data and Mendelian randomization analysis to reveal the causal role of osteocalcin
by: Zhiyang Zheng, et al.
Published: (2026)

Biomarkers in Alzheimer's disease clinical trials: 2025
by: Amanda M. Leisgang Osse, et al.
Published: (2026)